Net Cash Provided by (Used in) Operating Activities of TC BioPharm (Holdings) plc from 31 Dec 2022 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD and GBP
Description
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary
TC BioPharm (Holdings) plc annual Net Cash Provided by (Used in) Operating Activities in USD history and change rate from 31 Dec 2022 to 31 Dec 2024.TC BioPharm (Holdings) plc annual and quarterly Net Cash Provided by (Used in) Operating Activities in GBP history and change rate from 31 Dec 2022 to 31 Dec 2024.
  • TC BioPharm (Holdings) plc Net Cash Provided by (Used in) Operating Activities for the quarter ending 31 Mar 2024 was £2,408,593, a 17% increase year-over-year.
  • TC BioPharm (Holdings) plc annual Net Cash Provided by (Used in) Operating Activities for 2024 was £12,567,288, a 19% decline from 2023.
  • TC BioPharm (Holdings) plc annual Net Cash Provided by (Used in) Operating Activities for 2023 was £10,544,870, a 31% increase from 2022.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, Annual (GBP)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Change (%)
Net Cash Provided by (Used in) Operating Activities, Quarterly (GBP)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Change (%)

TC BioPharm (Holdings) plc Annual Net Cash Provided by (Used in) Operating Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $15,800,000 01 Jan 2024 31 Dec 2024 20-F 09 May 2025 2024 FY

TC BioPharm (Holdings) plc Annual Net Cash Provided by (Used in) Operating Activities (GBP)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 £12,567,288 -£2,022,418 -19% 01 Jan 2024 31 Dec 2024 20-F 09 May 2025 2024 FY
2023 £10,544,870 +£4,747,427 +31% 01 Jan 2023 31 Dec 2023 20-F 09 May 2025 2024 FY
2022 £15,292,297 01 Jan 2022 31 Dec 2022 20-F 09 May 2025 2024 FY

TC BioPharm (Holdings) plc Quarterly Net Cash Provided by (Used in) Operating Activities (GBP)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 £2,408,593 +£502,654 +17% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q1 2023 £2,911,247 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.